Molecular – genetic diagnostics of Human Papillomavirus (HPV) and monitoring of HPV patients
MUDr. Lenka Oravcová, RNDr. Renáta Lukačková, Andrea Kucková
Human papillomaviruses (HPV) are considered to be a significant etiological factor responsible for over 99.7 % of all cervical carcinomas, while 14 of HPV types...
RNDr. Andrea Blahová, Nikola Chovanová, Kristína Lengyelová, MUDr. Lenka Oravcová, Kristína Juríková, Mgr. Jakub Petrík, Michaela Patáková-Zrubcová, RNDr. Renáta Lukačková
The myelodysplastic syndrome (MDS) is a heterogeneous group of clonal haematopoietic disorders originated in the bone marrow. It is characterized by ineffective haematopoiesis, dysplastic changes...
Molecular analysis of prognostically significant markers of chronic lymphocytic leukemia
Mgr. Erika Tomková, RNDr. Miroslav Tomka, PhD., RNDr. Renáta Lukačková, Mgr. Jakub Petrík
Chronic lymphocytic leukemia (CLL) is a clinically and biologically substantially heterogenous disease. In general, patients are classified into two groups: patients with indolent disease form...
Differential molecular diagnosis of multiple myeloma and Waldenström macroglobulinemia
Mgr. Lucia Tatayová, prof. MUDr. Beata Mladosievičová, CSc., RNDr. Renáta Lukačková
Multiple myeloma (MM) is a lymphoproliferative disease affecting the plasma B-lymphocytes. It is classified among monoclonal gammopathies as its major symptoms include production of monoclonal...
